LONDON--(BUSINESS WIRE)--Technavio has been monitoring the contract development and manufacturing organization (CDMO) outsourcing market and it is poised to grow by USD 44.17 billion during 2020-2024, ...
The CDMO market offers growth opportunities via increasing demand for biologic therapies and strategic collaborations due to rising drug complexity and strong R&D funding. Challenges include supply ...
Dublin, Jan. 21, 2026 (GLOBE NEWSWIRE) -- The "Pharmaceutical Contract Manufacturing Organization (CMO) - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)" has been ...
Pluri, an established global leader in the development and manufacturing of cell-based therapeutics, launches new revenue-generating Contract Development and Manufacturing Organization (CDMO) division ...
DUBLIN--(BUSINESS WIRE)--The "Global Small Molecule Contract Development and Manufacturing Organization (CDMO) Market Growth Opportunities, 2023" report has been added to ResearchAndMarkets.com's ...
The "mRNA Therapeutics Contract Development & Manufacturing Organization Market Size, Share & Trends Analysis Report By Indication (Metabolic & Genetic Diseases), By Application, By End Use, By Region ...
“The global API manufacturing market is going through some major changes these days,” says Sean O’Brien, COO, Abzena. He ...
Outsourcing offers expertise beyond facilities, but sponsors need strategic CDMO partnerships for peptide therapeutics, cell ...
HAIFA, Israel, Jan. 08, 2024 (GLOBE NEWSWIRE) -- Pluri Inc. (Nasdaq: PLUR) (TASE: PLUR) (“Pluri” or the “Company”), a leading biotech company that transforms cells into solutions that promote global ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results